Farbod Sedaghat-Hamedani

20PUBLICATIONS
160CO-AUTHORS
BiomechanicsCardiology (incl. cardiovascular diseases)Decision makingMajor global burdens of diseaseGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Sep 04, 2026
Physical Activity in Arrhythmogenic Cardiomyopathy: From Trigger to Therapeutic Dilemma.

|Jul 13, 2026
RBM20 variants disrupt Ca2+ handling and metabolism in dilated and non-compaction cardiomyopathy stem cell models.

|Jul 01, 2026
Real-World Evaluation of Guideline-Directed Treatments in Patients With Obstructive Hypertrophic Cardiomyopathy in Germany.

|Feb 24, 2026
Design, implementation and analysis of a quality assurance process for Informed Consents using the DZHK registry TORCH-DZHK1 as an example.

Dana Stahl, Katrin Leyh, Alexander Rudolph

|Feb 09, 2026
Targeting the Sarcomere: Myosin Inhibitors as the Revolutionary Game Changer in Hypertrophic Cardiomyopathy.

Farbod Sedaghat-Hamedani, Elham Kayvanpour, Benjamin Meder

|Oct 27, 2025
Clinical and economic burden associated with symptomatic and asymptomatic obstructive hypertrophic cardiomyopathy in Germany.

Farbod Sedaghat-Hamedani, Carla L Zema, Michael Schultze

Pageof 4

Frequent Collaborators

12 joint publications

Elham Kayvanpour

6 joint publications

Benjamin Meder

3 joint publications

Christoph Reich

3 joint publications

Ziya Kaya